Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2012; 18(43): 6302-6307
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6302
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6302
Center | UBT | n | H. pylori eradication rate (%) | |||
POCA | OCAP | OCA | Total | |||
01 | C13 | 52 | 83.3 (15/18) | 80.0 (12/15) | 52.6 (10/19) | 71.2 |
02 | C13 | 29 | 80.0 (8/10) | 90.0 (9/10) | 88.9 (8/9) | 86.2 |
03 | C14 | 30 | 70.0 (7/10) | 50.0 (5/10) | 30.0 (3/10) | 50.0 |
04 | C13 | 29 | 80.0 (8/10) | 88.9 (8/9) | 70.0 (7/10) | 79.3 |
05 | C14 | 30 | 100 (10/10) | 70.0 (7/10) | 60.0 (6/10) | 76.7 |
06 | C14 | 29 | 88.9 (8/9) | 100 (10/10) | 40.0 (4/10) | 75.9 |
07 | C14 | 29 | 66.7 (6/9) | 100 (10/10) | 100 (10/10) | 89.7 |
-
Citation: Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, Guo CY, Xu P, Gong YF, Li ZS. Adjuvant probiotics improve the eradication effect of triple therapy for
Helicobacter pylori infection. World J Gastroenterol 2012; 18(43): 6302-6307 - URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6302